BX Swiss TOP 30 CHF
|
1 340,93
|
10,00
|
0,75 %
|
Analysen zu BX Swiss TOP 30 CHF-Werten
| 19.06.24 | Richemont Outperform | Bernstein Research | |
| 18.06.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 18.06.24 | ABB Hold | Jefferies & Company Inc. | |
| 17.06.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 17.06.24 | Roche Hold | Deutsche Bank AG | |
| 17.06.24 | Roche Equal Weight | Barclays Capital | |
| 17.06.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 14.06.24 | Nestlé Buy | UBS AG | |
| 14.06.24 | Givaudan Hold | Deutsche Bank AG | |
| 14.06.24 | Nestlé Market-Perform | Bernstein Research | |
| 11.06.24 | Nestlé Buy | Deutsche Bank AG | |
| 11.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 10.06.24 | Nestlé Buy | UBS AG | |
| 10.06.24 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 10.06.24 | Givaudan Equal Weight | Barclays Capital | |
| 05.06.24 | ABB Kaufen | DZ BANK | |
| 05.06.24 | Richemont Sector Perform | RBC Capital Markets | |
| 05.06.24 | Novartis Buy | Deutsche Bank AG | |
| 05.06.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.06.24 | Roche Hold | Deutsche Bank AG | |
| 03.06.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 03.06.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 03.06.24 | Swiss Re Sell | UBS AG | |
| 03.06.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Roche Neutral | UBS AG | |
| 31.05.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Novartis Buy | Jefferies & Company Inc. | |
| 31.05.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 31.05.24 | Richemont Buy | Deutsche Bank AG | |
| 30.05.24 | Nestlé Buy | UBS AG | |
| 30.05.24 | Nestlé Sector Perform | RBC Capital Markets | |
| 30.05.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 30.05.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 29.05.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 28.05.24 | Richemont Outperform | Bernstein Research | |
| 28.05.24 | Givaudan Hold | Deutsche Bank AG | |
| 24.05.24 | Richemont Outperform | Bernstein Research | |
| 24.05.24 | Roche Hold | Deutsche Bank AG | |
| 24.05.24 | Novartis Buy | Deutsche Bank AG |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.